BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grąt K, Grąt M, Rowiński O. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2020;8:E298. [PMID: 32839409 DOI: 10.3390/biomedicines8090298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Veltkamp C, Lan S, Korompoki E, Weiss K, Schmidt H, Seitz HK. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. JCM 2022;11:2623. [DOI: 10.3390/jcm11092623] [Reference Citation Analysis]
2 Xia Y, Li J, Chen K, Feng J, Guo C. Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway. PPAR Res 2020;2020:6694214. [PMID: 33488687 DOI: 10.1155/2020/6694214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
3 Shao CX, Ye J, Dong Z, Li F, Lin Y, Liao B, Feng S, Zhong B. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease. Ther Adv Chronic Dis 2021;12:20406223211033119. [PMID: 34408822 DOI: 10.1177/20406223211033119] [Reference Citation Analysis]
4 Baumgartner S, Shiri-Sverdlov R. NASH and Systemic Complications: From Basic to Clinical Research. Biomedicines 2021;9:1913. [PMID: 34944726 DOI: 10.3390/biomedicines9121913] [Reference Citation Analysis]